You are here

Article Text

Article menu
Download PDFPDF
Review
Unexplained fractures in infancy: looking for fragile bones

https://doi.org/10.1136/adc.2006.106120

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: NB receives grant support from the Arthritis Research Campaign and the Wellcome Trust to study bone disease in children and infants, and from Procter and Gamble, Sanofi-Aventis and Novartis pharmaceuticals to undertake studies of bisphosphonates in children with osteogenesis imperfecta. NB and AS undertake medical work remunerated through the Legal Aid Fund in the field of unexplained fractures in infancy. NB has a particular interest in the genetic causes of bone fragility in infancy and childhood. AD is director of the Sheffield Molecular Diagnostic Service, which provides testing of COL1A1 and COL1A2.

    Linked Articles

    • Précis
      A brief digest of the March issue
      BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
      Archives of Disease in Childhood 2007; 92 e3-e3 Published Online First: 02 Mar 2007.